PhRMA and ClinicalTrials.gov

Executive Summary

Industry compliance with the ClinicalTrials.gov database was discussed at a July 15 board meeting of the Pharmaceutical Research & Manufacturers of America. "The heads of regulatory affairs at PhRMA member companies have said they believe they are in compliance" with ClinicalTrials.gov posting requirements. Data cited by Rep. Henry Waxman (D-Calif.) during a recent congressional hearing do not reflect the current rate of compliance, PhRMA said (1"The Pink Sheet" July 12, 2004, p. 4). The association believes a "fairer evaluation would look at what our companies submitted in 2003 and so far this year"...